Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3,5-dimethyl-4-[[2-([(3R)-1-[(pyridin-4-yl)methyl]pyrrolidin-3-yl]amino)thieno[3,2-d]pyrimidin-4-yl]oxy]benzonitrile | exceptionally potent against a wide range of HIV-1 strains carrying single NNRTI-resistant mutations | Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([(3S)-1-[(pyridin-4-yl)methyl]pyrrolidin-3-yl]amino)thieno[3,2-d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([1-[(4-nitrophenyl)methyl]-1,2,3,4-tetrahydropyridin-4-yl]amino)-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([1-[(4-nitrophenyl)methyl]piperidin-4-yl]amino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([1-[(4-nitrophenyl)methyl]piperidin-4-yl]amino)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([1-[(4-nitrophenyl)methyl]piperidin-4-yl]amino)-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([1-[(4-nitrophenyl)methyl]piperidin-4-yl]amino)-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([1-[(pyridin-4-yl)methyl]azepan-4-yl]amino)thieno[3,2-d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([1-[(pyridin-4-yl)methyl]azetidin-3-yl]amino)thieno[3,2-d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([1-[(pyridin-4-yl)methyl]piperidin-4-yl]amino)-5,6,7,8-tetrahydroquinazolin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([1-[(pyridin-4-yl)methyl]piperidin-4-yl]amino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([1-[(pyridin-4-yl)methyl]piperidin-4-yl]amino)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([1-[(pyridin-4-yl)methyl]piperidin-4-yl]amino)-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3,5-dimethyl-4-[[2-([8-[(pyridin-4-yl)methyl]-8-azabicyclo[3.2.1]octan-3-yl]amino)thieno[3,2-d]pyrimidin-4-yl]oxy]benzonitrile | - |
Human immunodeficiency virus 1 | |
3-[(3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
3-[(3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]azetidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
3-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl]amino]piperidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
3-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
3-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
3-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
3-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
3-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]azepan-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
3-[[(3R)-3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]pyrrolidin-1-yl]methyl]benzamide | exceptionally potent against a wide range of HIV-1 strains carrying single NNRTI-resistant mutations. Favorable pharmacokinetic properties with an oral bioavailability of 30.96% and a half-life of 11.1 h.Ppromising anti-HIV-1 drug candidate with potent antiviral activities and desirable drug-like properties. | Human immunodeficiency virus 1 | |
3-[[(3S)-3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]pyrrolidin-1-yl]methyl]benzamide | - |
Human immunodeficiency virus 1 | |
4-((4-((4-(4-cyano-2,6-dimethylphenoxy)-5,7-dihydrofuro-[3,4-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzamide | - |
Human immunodeficiency virus 1 | |
4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]-1,2,3,4-tetrahydropyridin-4-yl)amino]-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]azepan-4-yl)amino]thieno[3,2-d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]azetidin-3-yl)amino]thieno[3,2-d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]piperidin-4-yl)amino]-5,6,7,8-tetrahydroquinazolin-4-yl]oxy)-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]piperidin-4-yl)amino]-5,7-dihydrofuro[3,4-d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]piperidin-4-yl)amino]-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]piperidin-4-yl)amino]-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]piperidin-4-yl)amino]-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
4-([2-[(8-[[4-(methanesulfonyl)phenyl]methyl]-8-azabicyclo[3.2.1]octan-3-yl)amino]thieno[3,2-d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
4-[(2-[[(3R)-1-[[4-(methanesulfonyl)phenyl]methyl]pyrrolidin-3-yl]amino]thieno[3,2-d]pyrimidin-4-yl)oxy]-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
4-[(2-[[(3S)-1-[[4-(methanesulfonyl)phenyl]methyl]pyrrolidin-3-yl]amino]thieno[3,2-d]pyrimidin-4-yl)oxy]-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
4-[(3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
4-[(3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]-8-azabicyclo[3.2.1]octan-8-yl)methyl]benzene-1-sulfonamide | - |
Human immunodeficiency virus 1 | |
4-[(3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]azetidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
4-[(3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]azetidin-1-yl)methyl]benzene-1-sulfonamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl]amino]piperidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl]amino]piperidin-1-yl)methyl]benzene-1-sulfonamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzene-1-sulfonamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,7-dihydrothieno[3,4-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzene-1-sulfonamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzene-1-sulfonamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzene-1-sulfonamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzene-1-sulfonamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]azepan-1-yl)methyl]benzamide | - |
Human immunodeficiency virus 1 | |
4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]azepan-1-yl)methyl]benzene-1-sulfonamide | - |
Human immunodeficiency virus 1 | |
4-[[(3R)-3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]pyrrolidin-1-yl]methyl]benzamide | - |
Human immunodeficiency virus 1 | |
4-[[(3R)-3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]pyrrolidin-1-yl]methyl]benzene-1-sulfonamide | - |
Human immunodeficiency virus 1 | |
4-[[(3S)-3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]pyrrolidin-1-yl]methyl]benzamide | - |
Human immunodeficiency virus 1 | |
4-[[(3S)-3-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]pyrrolidin-1-yl]methyl]benzene-1-sulfonamide | - |
Human immunodeficiency virus 1 | |
4-[[2-([1-[(4-aminophenyl)methyl]piperidin-4-yl]amino)-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]oxy]-3,5-dimethylbenzonitrile | - |
Human immunodeficiency virus 1 | |
N-[4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]phenyl]methanesulfonamide | - |
Human immunodeficiency virus 1 |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Human immunodeficiency virus 1 | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
reverse transcriptase | - |
Human immunodeficiency virus 1 |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000051 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl]amino]piperidin-1-yl)methyl]benzamide | |
0.000051 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | |
0.000056 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3,5-dimethyl-4-[[2-([1-[(pyridin-4-yl)methyl]piperidin-4-yl]amino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yl]oxy]benzonitrile | |
0.000066 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | |
0.000072 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3,5-dimethyl-4-[[2-([1-[(pyridin-4-yl)methyl]piperidin-4-yl]amino)-5,6,7,8-tetrahydroquinazolin-4-yl]oxy]benzonitrile | |
0.000073 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | |
0.000074 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3,5-dimethyl-4-[[2-([1-[(pyridin-4-yl)methyl]piperidin-4-yl]amino)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]oxy]benzonitrile | |
0.000074 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzene-1-sulfonamide | |
0.000077 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]piperidin-4-yl)amino]-5,7-dihydrofuro[3,4-d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | |
0.000084 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl]amino]piperidin-1-yl)methyl]benzene-1-sulfonamide | |
0.000091 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | |
0.000091 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]-1,2,3,4-tetrahydropyridin-4-yl)amino]-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | |
0.000091 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzene-1-sulfonamide | |
0.000092 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3,5-dimethyl-4-[[2-([1-[(4-nitrophenyl)methyl]piperidin-4-yl]amino)-5,7-dihydrofuro[3,4-d]pyrimidin-4-yl]oxy]benzonitrile | |
0.000094 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3,5-dimethyl-4-[[2-([1-[(4-nitrophenyl)methyl]piperidin-4-yl]amino)-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidin-4-yl]oxy]benzonitrile | |
0.000094 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | |
0.0000989 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]piperidin-4-yl)amino]-5,6,7,8-tetrahydroquinazolin-4-yl]oxy)-3,5-dimethylbenzonitrile | |
0.000101 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,6,7,8-tetrahydroquinazolin-2-yl]amino]piperidin-1-yl)methyl]benzamide | |
0.000109 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzene-1-sulfonamide | |
0.000112 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3,5-dimethyl-4-[[2-([1-[(pyridin-4-yl)methyl]piperidin-4-yl]amino)-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]oxy]benzonitrile | |
0.000115 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-[[2-([1-[(4-aminophenyl)methyl]piperidin-4-yl]amino)-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]oxy]-3,5-dimethylbenzonitrile | |
0.000129 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3,5-dimethyl-4-[[2-([1-[(4-nitrophenyl)methyl]-1,2,3,4-tetrahydropyridin-4-yl]amino)-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]oxy]benzonitrile | |
0.00013 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]piperidin-4-yl)amino]-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | |
0.00014 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | N-[4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]phenyl]methanesulfonamide | |
0.000157 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-([2-[(1-[[4-(methanesulfonyl)phenyl]methyl]piperidin-4-yl)amino]-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]oxy)-3,5-dimethylbenzonitrile | |
0.000175 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3,5-dimethyl-4-[[2-([1-[(4-nitrophenyl)methyl]piperidin-4-yl]amino)-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]oxy]benzonitrile | |
0.000241 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3,5-dimethyl-4-[[2-([1-[(4-nitrophenyl)methyl]piperidin-4-yl]amino)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]oxy]benzonitrile | |
0.000241 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 3-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzamide | |
0.00041 | - |
inhibition against wild-type enzyme, pH and temperature not specified in the publication | Human immunodeficiency virus 1 | 4-[(4-[[4-(4-cyano-2,6-dimethylphenoxy)-5,7-dihydrothieno[3,4-d]pyrimidin-2-yl]amino]piperidin-1-yl)methyl]benzene-1-sulfonamide |
General Information | Comment | Organism |
---|---|---|
drug target | 4-((4-((4-(4-cyano-2,6-dimethylphenoxy)-5,7-dihydrofuro-[3,4-d]pyrimidin-2-yl)amino)piperidin-1-yl)methyl)benzamide is a promising anti-HIV-1 drug candidate with potent antiviral activities and desirable drug-like properties | Human immunodeficiency virus 1 |